Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases ; volume:6 ; number:1 ; day:31 ; month:8 ; year:2018 ; pages:1-6 ; date:12.2018
Journal for ImmunoTherapy of Cancer ; 6, Heft 1 (31.8.2018), 1-6, 12.2018
- Creator
-
Garcia, Christine A.
- Contributor
-
El-Ali, Alex
Rath, Tanya J.
Contis, Lydia C.
Gorantla, Vikram
Drappatz, Jan
Davar, Diwakar
SpringerLink (Online service)
- DOI
-
10.1186/s40425-018-0393-z
- URN
-
urn:nbn:de:101:1-2018102113025472113342
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Garcia, Christine A.
- El-Ali, Alex
- Rath, Tanya J.
- Contis, Lydia C.
- Gorantla, Vikram
- Drappatz, Jan
- Davar, Diwakar
- SpringerLink (Online service)
Other Objects (12)
Neurologic adverse events of cancer immunotherapy
Managing immune-related adverse events in oncology
Gene expression profiling of whole blood in ipilimumab-treated patients for identification of potential biomarkers of immune-related gastrointestinal adverse events
Herpes Encephalitis: A Mortal Complication in a Patient Treated with Immunosuppressive Drugs because of Immune-Related Adverse Events after Ipilimumab Treatment
Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report
Myocarditis as an immune-related adverse event following treatment with ipilimumab and nivolumab combination therapy for metastatic renal cell carcinoma: a case report
Corticosteroid-resistant immune-related adverse events: a systematic review
Stage IV renal cell carcinoma achieves pathologic complete response after two ipilimumab plus nivolumab courses despite severe immune-related adverse events: a case report
Nivolumab adjuvant, Nivolumab plus Ipilimumab : Meilensteine in der Behandlung des malignen Melanoms
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors
Editorial: Immune-Related Adverse Events for Patients With Lung Cancer
The role of tumor types in immune-related adverse events
Neurologic adverse events of cancer immunotherapy
Managing immune-related adverse events in oncology
Gene expression profiling of whole blood in ipilimumab-treated patients for identification of potential biomarkers of immune-related gastrointestinal adverse events
Herpes Encephalitis: A Mortal Complication in a Patient Treated with Immunosuppressive Drugs because of Immune-Related Adverse Events after Ipilimumab Treatment
Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report
Myocarditis as an immune-related adverse event following treatment with ipilimumab and nivolumab combination therapy for metastatic renal cell carcinoma: a case report
Corticosteroid-resistant immune-related adverse events: a systematic review
Stage IV renal cell carcinoma achieves pathologic complete response after two ipilimumab plus nivolumab courses despite severe immune-related adverse events: a case report
Nivolumab adjuvant, Nivolumab plus Ipilimumab : Meilensteine in der Behandlung des malignen Melanoms
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors
Editorial: Immune-Related Adverse Events for Patients With Lung Cancer
The role of tumor types in immune-related adverse events
Neurologic adverse events of cancer immunotherapy
Managing immune-related adverse events in oncology
Gene expression profiling of whole blood in ipilimumab-treated patients for identification of potential biomarkers of immune-related gastrointestinal adverse events
Herpes Encephalitis: A Mortal Complication in a Patient Treated with Immunosuppressive Drugs because of Immune-Related Adverse Events after Ipilimumab Treatment
Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report
Myocarditis as an immune-related adverse event following treatment with ipilimumab and nivolumab combination therapy for metastatic renal cell carcinoma: a case report
Corticosteroid-resistant immune-related adverse events: a systematic review
Stage IV renal cell carcinoma achieves pathologic complete response after two ipilimumab plus nivolumab courses despite severe immune-related adverse events: a case report
Nivolumab adjuvant, Nivolumab plus Ipilimumab : Meilensteine in der Behandlung des malignen Melanoms
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors
Editorial: Immune-Related Adverse Events for Patients With Lung Cancer